bioMérieux (BMXMF) News Today $116.49 +5.58 (+5.03%) As of 01/17/2025 03:27 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest UpdatebioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) saw a significant decrease in short interest in December. As of December 31st, there was short interest totalling 118,300 shares, a decrease of 19.1% from the December 15th total of 146,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 1,183.0 days.January 16, 2025 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Growth in Short InterestbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 139,000 shares, a growth of 6.6% from the November 15th total of 130,400 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 1,390.0 days.December 15, 2024 | marketbeat.comRBC Capital attribue une note de surperformance à l'action BioMerieuxDecember 11, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Shares Up 3% - What's Next?bioMérieux (OTCMKTS:BMXMF) Shares Up 3% - Time to Buy?November 30, 2024 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Stock Crosses Below Fifty Day Moving Average - What's Next?bioMérieux (OTCMKTS:BMXMF) Stock Price Crosses Below 50 Day Moving Average - Here's What HappenedNovember 8, 2024 | marketbeat.combioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Down 20.2% in OctoberbioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) was the target of a significant decline in short interest during the month of October. As of October 15th, there was short interest totalling 128,700 shares, a decline of 20.2% from the September 30th total of 161,300 shares. Based on an average trading volume of 5,000 shares, the days-to-cover ratio is presently 25.7 days.October 28, 2024 | marketbeat.comLe large parc installé de BioMerieux considéré comme un avantage clé - HSBCOctober 17, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Stock Crosses Below 50 Day Moving Average - Time to Sell?bioMérieux (OTCMKTS:BMXMF) Share Price Crosses Below 50 Day Moving Average - Time to Sell?October 9, 2024 | marketbeat.comShort Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Drops By 26.8%bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) saw a significant decline in short interest in September. As of September 15th, there was short interest totalling 165,200 shares, a decline of 26.8% from the August 31st total of 225,800 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 1,652.0 days.September 28, 2024 | marketbeat.combioMérieux S.A. (BMXMF)September 18, 2024 | finance.yahoo.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $122.52bioMérieux (OTCMKTS:BMXMF) Reaches New 12-Month High at $122.52September 11, 2024 | marketbeat.comBerenberg Bank Keeps Their Buy Rating on bioMerieux (0RUG)September 11, 2024 | markets.businessinsider.comKepler Capital Reaffirms Their Buy Rating on bioMerieux (0RUG)September 7, 2024 | markets.businessinsider.comUBS maintient sa note d'achat sur BioMerieux, voit la force de la R&DSeptember 6, 2024 | fr.investing.combioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $120.00bioMérieux (OTCMKTS:BMXMF) Sets New 52-Week High at $120.00September 5, 2024 | marketbeat.combioMérieux (OTCMKTS:BMXMF) Hits New 52-Week High at $119.62bioMérieux (OTCMKTS:BMXMF) Reaches New 52-Week High at $119.62August 28, 2024 | marketbeat.combioMerieux (0RUG) Gets a Buy from Kepler CapitalAugust 28, 2024 | markets.businessinsider.comHologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among ThemAugust 27, 2024 | seekingalpha.comUBS Group Upgrades bioMérieux (OTCMKTS:BMXMF) to "Strong-Buy"UBS Group upgraded shares of bioMérieux to a "strong-buy" rating in a research note on Thursday.August 24, 2024 | marketbeat.comUBS voit l'action BioMerieux prête à croître grâce à la plateforme disruptive SPOTFIREAugust 22, 2024 | fr.investing.comBaxter International Inc. (BAX)July 27, 2024 | finance.yahoo.comBioMerieux SA BIMMay 17, 2024 | morningstar.comBMXMF bioMérieux S.A.May 8, 2024 | seekingalpha.comBiomerieux/adr's Net WorthMarch 6, 2024 | benzinga.comOxford Nanopore Shares Rise on Backed Guidance, GBP70 Mln Investment by bioMerieuxOctober 19, 2023 | marketwatch.combioMerieux : les résultats 2022 devraient se situer dans la borne haute des intervalles publiés en aoûtOctober 26, 2022 | msn.combioMerieux : du mieuxApril 13, 2022 | msn.combioMerieux recule après les annoncesApril 12, 2022 | msn.combioMérieux S.A. GAAP EPS of €5.06, revenue of €3.37MMarch 3, 2022 | seekingalpha.comFrench multidisciplinary consortium ARPEGE awarded public funding of close to €9 million to fight antibiotic resistanceJanuary 7, 2022 | finance.yahoo.comBaxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney InjuryOctober 21, 2021 | finance.yahoo.combioMerieux to Exhibit at SupplySide West 2021 at Mandalay Bay in Las Vegas Oct. 25-28, 2021October 5, 2021 | finance.yahoo.com Get bioMérieux News Delivered to You Automatically Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter. Email Address BMXMF Media Mentions By Week BMXMF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMXMF News Sentiment▼1.460.49▲Average Medical News Sentiment BMXMF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMXMF Articles This Week▼10▲BMXMF Articles Average Week Get bioMérieux News Delivered to You Automatically Sign up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BMWYY News Today MHVYF News Today ADYEY News Today BAMXF News Today HOCPY News Today JAPAY News Today BAESY News Today CAIXY News Today DHLGY News Today SVNDY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BMXMF) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioMérieux S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioMérieux With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.